The Valley Desk

ArticleJCO precision oncologyPublished

Trametinib in Patients With NF1-, GNAQ-, or GNA11-Mutant Tumors: Results From the NCI-MATCH ECOG-ACRIN Trial (EAY131) Subprotocols S1 and S2

Read the publication ↗ Open access copy ↗

Regional connection

Verified Author affiliations on the Europe PMC record name Thomas Jefferson University Hospital, University of Pennsylvania, with Jefferson Health linked by the institution reference. Affiliation source

Publication record

Type
Article
Venue
JCO precision oncology
Published
Subject terms
Humans; Melanoma; Neurofibromatosis 1; Pyridones; Pyrimidinones; GTP-Binding Protein alpha Subunits; GTP-Binding Protein alpha Subunits, Gq-G11
PubMed ID
37053535
PubMed Central ID
PMC10309549
Open access
Yes, open
Added to directory
Source checked

Report a correction or request removal